13239330_10101975020026334_634863807371976158_n


“Meningitis is a rare disease that affects only 390 people nationally last year.”


Reality: More recently (perhaps thanks to vaccination rates) there has been less than 700 cases reported per year. (2) “During 2005-2011, an estimated 800-1,200 cases of meningococcal disease occurred annually in the United States, representing an incidence of 0.3 cases per 100,000 population.” (1)

“73% of all cases of meningococcal disease among persons 11 years of age or older.” (1)

“The case-fatality ratio of meningococcal disease is 10% to 15%, even with appropriate antibiotic therapy. The case-fatality ratio of meningococcemia is up to 40%. As many as 20% of survivors have permanent sequelae (disease related effects), such as hearing loss, neurologic damage, or loss of a limb.” (1)


 “FDA and Industry testing show the meningitis vaccine to be unusually low efficacy and high risk.”


Reality: The efficacies of the vaccines are not extremely low.


Meningococcal Polysaccharide Vaccine: “Serogroups A and C have demonstrated estimated clinical efficacies of 85% or more among school-aged children and adults during outbreaks.” (1)


Meningococcal Conjugate Vaccines: “Because of the low incidence of serogroup B meningococcal disease, MenB vaccine efficacy estimates were based on demonstration of an immune response after vaccination. From 63% to 88% of recipients of a full series of MenB vaccine develop a protective level of antibody against representative strains of serogroup B meningococcus.” (2)


“The Manufacturers inserts predict that 1% to 1.3% of inoculated children will suffer serious adverse effects.”


Reality: RFKjr is citing adverse events.


Adverse Event: “is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. (3)


Meningococcal Polysaccharide Vaccine

“Fever (100°F – 103°F) within 7 days of vaccination is reported for up to 3% of recipients. Systemic reactions, such as headache and malaise, within 7 days of vaccination are reported for up to 60% of recipients. Fewer than 3% of recipients reported these systemic reactions as severe.” (1)


Meningococcal Conjugate Vaccine

“The most frequently reported adverse events for MenACWY-D include fever (16.8%), headache (16.0%) injection site erythema (14.6%), and dizziness (13.4%). Syncope was reported in 10.0% of reports involving MenACWY-D. Of all reported MenACWY-D events, 6.6% were coded as serious (i.e., resulted in death, life-threatening illness, hospitalization, prolongation of hospitalization, or permanent disability). Serious events included headache, fever, vomiting, and nausea. A total of 24 deaths (0.3%) were reported.” (1)


“The CDC’s Pink Book forecasts that 0.3% of these children will die from the vaccine.”


Reality: Not a single death can be attributed to the vaccine. 

“Among the 24 reports of death, 11 (45.8%) indicated that the cause of death was meningococcal infection (nine with a serogroup included in the vaccine and two with a nonvaccine serogroup). Among the other 13 (54.2%) reports of death, which occurred from the day of vaccination to 127 days following vaccination, stated causes of death were cardiac (five), neurologic (two), infectious (two), behavioral (i.e., suicide) (two), rheumatologic (one), and unexplained (one). There was no pattern among these reports. Except for the finding of GBS, which was further evaluated and is discussed below, no signals were identified in VAERS after MenACWY-D vaccination.” (5)


Real Risks

Adverse Reactions:

Meningococcal Polysaccharide Vaccine

“Adverse reactions to MPSV4 are generally mild. The most frequent are local reactions, such as pain and redness at the injection site. These reactions last for 1 or 2 days, and occur in up to 48% of recipients.” (1)


Meningococcal Conjugate Vaccine

“More than 60,000 persons have received MenB vaccines during clinical trials or for outbreak control on college campuses. The most common side effect was pain at the injection site, which was reported by about 80% of recipients.” (2)


“Of the 400,000 New York school children inoculated annually, some 4,000 will become ill and nine will die in order to prevent around four people from contracting the disease.”


Reality: This is simply not true, as proven above.

“At between $84 and $117 per shot, and with the requirement for a two-shot series, the law is an $80 million annual windfall for vaccine manufacturers at taxpayer expense.”


Reality: RFKjr did get the roundabout price of the vaccines correct (4). Although this would only come out of your pocket, if you do not have health insurance or it wasn’t covered by your health insurance. I believe the statement “at taxpayer expense” is used to resonate with someone reading this meme; “wait I have to pay for this?” Essentially it is a misleading statement meant to be inflammatory.


Sources:

  1. The CDC Pink Book: Meningococcal Disease 
  2. Meningococcal: Questions and Answers
  3. Definition of adverse event.
  4. Vaccine Prices
  5. Epi Ren

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s